Richard B. Wilder

4.1k total citations
94 papers, 2.6k citations indexed

About

Richard B. Wilder is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Radiation. According to data from OpenAlex, Richard B. Wilder has authored 94 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 35 papers in Pathology and Forensic Medicine and 26 papers in Radiation. Recurrent topics in Richard B. Wilder's work include Lymphoma Diagnosis and Treatment (32 papers), Advanced Radiotherapy Techniques (26 papers) and Prostate Cancer Diagnosis and Treatment (25 papers). Richard B. Wilder is often cited by papers focused on Lymphoma Diagnosis and Treatment (32 papers), Advanced Radiotherapy Techniques (26 papers) and Prostate Cancer Diagnosis and Treatment (25 papers). Richard B. Wilder collaborates with scholars based in United States, Canada and Italy. Richard B. Wilder's co-authors include James D. Cox, Fernando Cabanillas, Chul S. Ha, Mark A. Hess, Gregory M. Chronowski, David S. Shimm, Conrad T. E. Pappas, John T. Manning, Susan L. Tucker and Sally J. DeNardo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Richard B. Wilder

93 papers receiving 2.5k citations

Peers

Countries citing papers authored by Richard B. Wilder

Since Specialization

Citations

This map shows the geographic impact of Richard B. Wilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Wilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Wilder more than expected).

Fields of papers citing papers by Richard B. Wilder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Wilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Wilder. The network helps show where Richard B. Wilder may publish in the future.

Co-authorship network of co-authors of Richard B. Wilder

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Wilder. A scholar is included among the top collaborators of Richard B. Wilder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Wilder. Richard B. Wilder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Laboratory Study of Collisionless Magnetic Reconnection 2023 ·Space Science Reviews ·Hantao Ji, Jongsoo Yoo, W. Fox, M. Yamada, M. R. Argall, J. Egedal, (unknown), Richard B. Wilder, S. Eriksson, W. Daughton, (unknown), Sayak Bose, J. L. Burch, R. B. Torbert, Jonathan Ng, Li‐Jen Chen	18
2	A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy 2014 ·Radiotherapy and Oncology ·Tobin J. Strom, Richard B. Wilder, Daniel C. Fernandez, Eric A. Mellon, Amarjit Saini, Dylan Hunt, Julio M. Pow‐Sang, (unknown), Wade J. Sexton, Michael Poch, Matthew C. Biagioli	49
3	A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer 2014 ·Practical Radiation Oncology ·Eric A. Mellon, (unknown), Tobin J. Strom, Eduardo G. Moros, Matthew C. Biagioli, Daniel C. Fernandez, (unknown), Richard B. Wilder	25
4	Altered Fractionation Schedules in Radiation Treatment: A Review 2014 ·Seminars in Oncology ·Kamran A. Ahmed, Candace R. Correa, Thomas J. Dilling, Nikhil G. Rao, Ravi Shridhar, Andy Trotti, Richard B. Wilder, Jimmy J. Caudell	30
5	Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer 2014 ·International Journal of Clinical Oncology ·A.O. Naghavi, Tobin J. Strom, (unknown), (unknown), Nicholas Figura, (unknown), Binglin Yue, Jongphil Kim, Matthew C. Biagioli, Daniel C. Fernandez, Randy V. Heysek, Richard B. Wilder	10
6	ACR Appropriateness Criteria® on Hodgkin's Lymphoma-Unfavorable Clinical Stage I and II 2011 ·Journal of the American College of Radiology ·Prajnan Das, Andrea K. Ng, Louis S. Constine, Ranjana H. Advani, Christopher R. Flowers, Jonathan W. Friedberg, David Hodgson, Cindy L. Schwartz, Richard B. Wilder, Lynn D. Wilson, Michael J. Yunes	1
7	Cross-Linked Hyaluronan Gel Reduces the Acute Rectal Toxicity of Radiotherapy for Prostate Cancer 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Richard B. Wilder, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Albert Mesa, (unknown), (unknown), (unknown), (unknown), Kenneth Tokita	61
8	Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease 2004 ·American Journal of Clinical Oncology ·Gregory M. Chronowski, Richard B. Wilder, Larry B. Levy, E. Neely Atkinson, Chul S. Ha, Fredrick B. Hagemeister, İbrahim Barışta, Maria Alma Rodriguez, Andreas H. Sarris, Mark A. Hess, Fernando Cabanillas, James D. Cox	24
9	Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II 2003 ·International Journal of Radiation OncologyBiologyPhysics ·Jeff M. Michalski, Kathryn Winter, James A. Purdy, Richard B. Wilder, Carlos A. Perez, Mack Roach, Matthew Parliament, Alan Pollack, Arnold M. Markoe, William B. Harms, Howard M. Sandler, James D. Cox	56
10	Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on radiation therapy oncology group 9406 2002 ·Seminars in Radiation Oncology ·Jeff M. Michalski, Kathryn Winter, James A. Purdy, Richard B. Wilder, Carlos A. Perez, Mack Roach, Matthew Parliament, (unknown), Arnold M. Markoe, William B. Harms, Howard M. Sandler, James D. Cox	23
11	Outcomes Using Doxorubicin-Based Chemotherapy with or without Radiotherapy for Early-Stage Peripheral T-cell Lymphomas 2002 ·Leukemia & lymphoma ·Hoon K. Lee, Richard B. Wilder, Dan Jones, Chul S. Ha, Barbara Pro, Maria Alma Rodriguez, Jorge Romaguera, Fernando Cabanillas, José Rodríguez, James D. Cox	12
12	An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease 2002 ·Cancer ·Gregory M. Chronowski, Richard B. Wilder, Susan L. Tucker, Chul S. Ha, Andreas H. Sarris, Fredrick B. Hagemeister, İbrahim Barışta, Mark A. Hess, Fernando Cabanillas, James D. Cox	35
13	Clinical stage IEA–IIEA orbital lymphomas: outcomes in the era of modern staging and treatment 2001 ·Radiotherapy and Oncology ·Christopher E. Pelloski, Richard B. Wilder, (unknown), Mark A. Hess, Fernando Cabanillas, James D. Cox	39
14	Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma 2001 ·Cancer ·Chul S. Ha, Susan L. Tucker, Angel I. Blanco, Richard B. Wilder, Peter McLaughlin, Fernando Cabanillas, James D. Cox	4
15	Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy 2001 ·Cancer ·Gregory M. Chronowski, Chul S. Ha, Richard B. Wilder, Fernando Cabanillas, John T. Manning, James D. Cox	231
16	Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III–IV, intermediate grade and large-cell immunoblastic lymphomas 2000 ·International Journal of Radiation OncologyBiologyPhysics ·Pamela J. Schlembach, Richard B. Wilder, Susan L. Tucker, Chul S. Ha, Maria Alma Rodriguez, Mark A. Hess, Fernando Cabanillas, James D. Cox	24
17	Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 2000 ·International Journal of Radiation OncologyBiologyPhysics ·Jeff M. Michalski, James A. Purdy, Kathryn Winter, Mack Roach, Srinivasan Vijayakumar, Howard M. Sandler, Arnold M. Markoe, (unknown), (unknown), Scott L. Sailer, William B. Harms, Carlos A. Perez, Richard B. Wilder, Gerald E. Hanks, James D. Cox	233
18	A comparison of arc-based and static mini-multileaf collimator-based radiosurgery treatment plans 1997 ·Radiotherapy and Oncology ·Hideo Kubo, Conrad T. E. Pappas, Richard B. Wilder	49
19	Effects of stem cell factor on the growth and radiation survival of tumor cells. 1995 ·PubMed ·Chaoxiang Shui, (unknown), Bryan R. Leigh, Anne M. Turner, Richard B. Wilder, Susan J. Knox	4
20	Basal cell carcinoma treated with radiation therapy 1991 ·Cancer ·Richard B. Wilder, John M. Kittelson, David S. Shimm	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact